CLINICAL_TRIALS
trial_result
· 2012-10-10
Clinical Trial Update: Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL) [Phase 3]
Summary
A Phase 3 trial evaluating liposomal cytarabine for central nervous system treatment in high-risk acute lymphoblastic leukemia has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nordic Society for Pediatric Hematology and Oncology | Conditions: Acute Lymphoblastic Leukemia | Phase 3 | Status: SUSPENDED